ANXA10 and pancreatic adenocarcinoma: The co-localization of ANXA10 and CD24 in PDACs and high-grade neoplasia lesions suggests that these two markers may play roles in regulating the progression of pancreatic diseases and the development of pancreatic adenocarcinoma.